Bulletin
Investor Alert

New York Markets Open in:

Pfizer Inc.

NYS: PFE

GO
/marketstate/country/us

Before the Bell

PFE
/zigman2/quotes/202877789/composite

$

49.73

Change

+0.02 +0.04%

Volume

Volume 73

Dec 7, 2022, 4:45 a.m.

Real time quotes

/zigman2/quotes/202877789/composite

Previous close

$ 49.71

$ 49.71

Change

-1.02 -2.01%

Day low

Day high

$49.18

$50.85

Open
Open: 50.67

52 week low

52 week high

$41.45

$61.71

Open

Market cap

$284.76B

Average volume

20.82M

P/E ratio

9.57

Rev. per Employee

$1.26M

EPS

5.19

Dividend

0.40

Div yield

3.22%

Ex dividend date

11/3/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pfe

MarketWatch News on PFE

  1. Zantac Lawsuits Get Tossed. 3 Drug Stocks Soar on the News.

    5:09 p.m. Dec. 6, 2022

    - Josh Nathan-Kazis

  2. Johnson & Johnson stock falls Tuesday, underperforms market

    4:33 p.m. Dec. 6, 2022

    - MarketWatch Automation

  3. Moderna Inc. stock outperforms competitors despite losses on the day

    4:31 p.m. Dec. 6, 2022

    - MarketWatch Automation

  4. Covid Cases Are Rising. L.A. Could Bring Back Masks.

    5:23 p.m. Dec. 5, 2022

    - Josh Nathan-Kazis

  5. Johnson & Johnson stock falls Monday, still outperforms market

    4:33 p.m. Dec. 5, 2022

    - MarketWatch Automation

  6. Moderna Inc. stock falls Monday, underperforms market

    4:32 p.m. Dec. 5, 2022

    - MarketWatch Automation

  7. China begins to loosen COVID rules

    11:31 a.m. Dec. 5, 2022

    - Jaimy Lee

  8. Moderna Inc. stock outperforms competitors on strong trading day

    4:31 p.m. Dec. 2, 2022

    - MarketWatch Automation

  9. Musk Has a Plan to Bring Advertisers Back to Twitter

    8:04 a.m. Dec. 2, 2022

    - Callum Keown

  10. Housing Is in a Big Chill. Next Year Won't Be Any Warmer.

    12:01 a.m. Dec. 2, 2022

    - Shaina Mishkin

  11. Johnson & Johnson stock outperforms competitors on strong trading day

    4:33 p.m. Dec. 1, 2022

    - MarketWatch Automation

  12. Moderna Inc. stock outperforms competitors on strong trading day

    4:31 p.m. Dec. 1, 2022

    - MarketWatch Automation

  13. Moderna Inc. stock rises Wednesday, still underperforms market

    4:31 p.m. Nov. 30, 2022

    - MarketWatch Automation

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pfe

Other News on PFE

  1. GSK, Sanofi Shares Jump After U.S. Judge Dismisses Zantac Lawsuit

    8 min ago

    - Cecilia Butini

  2. After Zero-Covid, China’s Health Industry Faces Titanic Shift

    7:43 a.m. Dec. 6, 2022

    - Nathaniel Taplin

  3. Twitter Offers Incentives to Win Back Advertisers

    3:41 p.m. Dec. 1, 2022

    - Patience Haggin

  4. FDA Pulls Lilly’s Covid Antibody Drug

    6:15 p.m. Nov. 30, 2022

    - Peter Loftus

  5. China’s Failed Covid Vaccine Nationalism

    6:35 p.m. Nov. 29, 2022

    - The Editorial Board

  6. Chinese Protests Put Xi Jinping in a Bind

    4:56 p.m. Nov. 28, 2022

    - Lingling Wei

  7. New Covid-19 Booster Shots For This Fall: What to Know

    2:01 p.m. Nov. 22, 2022

    - Peter Loftus

  8. Japan Approves First Homegrown Covid-19 Antiviral Pill

    6:37 a.m. Nov. 22, 2022

    - Megumi Fujikawa

  9. Merck Strikes $1.35 Billion Deal for Bone-Marrow Disease Drug Developer

    7:18 a.m. Nov. 21, 2022

    - Jonathan D. Rockoff

  10. Elon Musk Can Save Twitter—and Democracy

    4:17 p.m. Nov. 20, 2022

    - Mark Weinstein

  11. IDNA: Healthcare Dashboard For November

    12:26 p.m. Nov. 16, 2022

    - Seeking Alpha

  12. Opioid reversal agent naloxone approvable for OTC use – FDA

    1:37 p.m. Nov. 15, 2022

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/pfe

Press Releases on PFE

  1. Pfizer PFE Technical Pivots with Risk Controls

    5:16 p.m. Nov. 28, 2022

    - Stock Traders Daily

  2. Pfizer PFE Investment Report

    3:13 a.m. Nov. 19, 2022

    - Stock Traders Daily

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.